Browsing: Wellness Tips

Aug 20 (Reuters) – Danish biosolutions maker Novonesis expects results in the second half of 2027 from research with Novo Nordisk into whether microbiome supplements could provide additional benefits alongside GLP-1 weight-loss drugs, its chief executive told Reuters

The Medicines and Healthcare products Regulatory Agency confirmed on 10 August that it had authorised orforglipron, sold under the brand name Foundayo, making Britain the first country in Europe to licence an oral GLP-1 receptor agonist for both weight management and type 2 diabetes. Julian Beach, the MHRA’s executive director of healthcare quality and access,…

For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss of 10 to 15% or more. Despite their success, however, scientists have not fully understood how these drugs work in the brain